Project documents | Leukaemia (acute myeloid, relapsed, refractory) - vosaroxin [ID746] | Guidance | NICE

Documents

Documents created during the development process.

Invitation to participate

Final scope (PDF 109 KB)

Published:

09 March 2017
Final matrix (PDF 98 KB)

Published:

09 March 2017
NICE's response to comments on the draft scope and provisional matrix (PDF 122 KB)

Published:

09 March 2017
Equality impact assessment (Scoping) (PDF 177 KB)

Published:

09 March 2017

Draft scope documents

Draft scope (pre-referral) (PDF 113 KB)

Published:

06 June 2016
Provisional matrix (pre-referral) (PDF 98 KB)

Published:

06 June 2016